Discontinuation report TEVA-DEFERASIROX

Last updated on 2019-11-01 History
Report ID 97589
Drug Identification Number 02407973
Brand name TEVA-DEFERASIROX
Common or Proper name DEFERASIROX
Company Name TEVA CANADA LIMITED
Active Ingredient(s) DEFERASIROX
Strength(s) 500MG
Dosage form(s) TABLET FOR SUSPENSION
Route of administration ORAL
Packaging size 30
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-10-31
Actual discontinuation date 2019-10-31
Remaining supply date 2019-10-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-11-01 English Compare
v2 2019-10-31 French Compare
v1 2019-10-31 English Compare